"10.1371_journal.pone.0060304","plos one","2013-04-23T00:00:00Z","Thomas Duning; Michael Deppe; Eva Brand; JÃ¶rg Stypmann; Charlotte Becht; Anna Heidbreder; Peter Young","Department of Neurology, University Hospital of Muenster, Muenster, Germany; Internal Medicine D, Department of Nephrology, Hypertension and Rheumatology, University Hospital Muenster, Muenster, Germany; Department of Cardiovascular Medicine, Division of Cardiology, University Hospital Muenster, Muenster, Germany; Department of Neurology, Section for Sleepmedicine, University Hospital Muenster, Muenster, Germany","Conceived and designed the experiments: TD MD EB JS CB AH PY. Performed the experiments: TD MD CB AH. Analyzed the data: TD MD EB JS CB AH PY. Contributed reagents/materials/analysis tools: TD MD EB JS CB AH PY. Wrote the paper: TD MD EB JS CB AH PY.","The authors have the following interests: Dr. Duning has received research support from Actelion, Genzyme; has participated in speaking engagements for Genzyme, Shire, Bristol-Myers Squibb, Boehringer-Ingelheim Pharma, Sanofi Aventis, Eisai, Novartis, Bayer Vital, Merz Pharma, Actelion, and Lundbeck. Prof. Dr. Brand has been on the advisory boards of Genzyme, Shire and Daiichi-Sankyo and has participated in speaking engagements for Genzyme, Shire and Daiichi-Sankyo. She has received research support from Genzyme and Shire. Prof. Dr. Young has participated in speaking engagements for Genzyme. Parts of the retrospective analysis of clinical data for this study were supported by Genzyme. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2013","04","Thomas Duning","TD",7,TRUE,7,4,7,7,TRUE,TRUE,FALSE,0,NA,FALSE
